1. Market Research
  2. > Healthcare
  3. > Blood Supply, Tissue Banking and Transplantation Market Trends
  4. > Plasma Fractionation Market by Product, Application & by End-user - Global Forecast to 2019

Over the last five years, the plasma fractionation market witnessed tremendous growth, primarily due to the growth in aging population, increasing number of hemophilic patients, rising use of IVIg, and high prevalence of chronic disorders across the globe.

In this report, the global plasma fractionation market is divided on the basis of product, application, and end user. Based on type of products, the plasma fractionation market is mainly segmented into albumin, immunoglobulins, coagulation factor concentrates, and others. The immunoglobulin segment is further subsegmented into intravenous immunoglobulin (IVIg), subcutaneous immunoglobulin (SCIg), and others. Coagulation factor concentrates are subsegmented into factor VIII, factor IX, factor XIII, prothrombin coagulation concentrates, Von Willebrand factor, and fibrinogen concentrates. The plasma fractionation application market is divided into neurology; hematology; immunology; critical care; and others. Likewise, the major end users analyzed in the plasma fractionation market are hospitals and clinics, clinical research laboratories, and academic institutes.

The global plasma market is expected to grow at a CAGR of 8.9% during the forecast period of 2014–2019. The market is mainly driven by the growth in aging population, increasing use of IVIg, growing number of hemophilic patients, and increasing diagnosis rate globally. However, the high cost of immunoglobulins and hemophilic drugs, stringent government regulations, and rapid increase in the use of recombinant products as an alternative to plasma-derived coagulation factor concentrates are hampering the growth of this market to a certain extent.

IVIg accounts for the major share of the plasma fractionation market. The increasing use of IVIg in clinical areas such as neurology, hematology, immunology, rheumatology, and dermatology, and its excellent efficacy records are the key factors responsible for the growth of this market segment. In addition, the use of IVIg is being evaluated for a wide range of conditions such as adult respiratory distress syndrome, fibrosis, connective tissue disease, encephalitis, heart failure, and Alzheimer’s disease. Positive results in such conditions would increase the demand for IVIg globally in the near future.

In 2013,, North America contribute the largest share to the global plasma fractionation market, followed by Europe, Asia-Pacific, and RoW. Developed geographies like North America and Europe are likely to grow at a lower CAGR as compared to the Asia-Pacific market, which is expected to witness the fastest growth during the forecast period, largely driven by the increasing aging population, increasing use of immunoglobulins, improved economy, rising number of hemophilic patients, growing use of albumin in China, increased accessibility to healthcare facilities, growth in the overall healthcare industry, and growing awareness of technologically advanced products in these regions.

The global plasma fractionation market is mainly dominated by six players that accounted for around 70% of the global plasma fractionation market in 2013. The major players in the global plasma fractionation market are Baxter International, Inc. (U.S.), Grifols SA (Spain), CSL Ltd. (Australia), Octapharma AG (Switzerland), Kedrion (Italy), Bio Product Laboratory (U.K.), Sanquin (Netherland), Laboratoire Français du Fractionnement et des Biotechnologies (France), and Biotest (Germany).

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping greater market share.

This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by top players in the plasma fractionation market. The report analyzes the plasma products by products, applications, and end users across all regions.
- Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the plasma fractionation market.
- Market Development: Comprehensive information on the lucrative emerging markets by products, application, end users, and region.
- Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the plasma fractionation market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analysis of leading players in the plasma fractionation market.

Table Of Contents

Plasma Fractionation Market by Product, Application and by End-user - Global Forecast to 2019


LIST OF TABLES

TABLE 1 IMPACT ANALYSIS OF RECOMBINANT FACTORS ON PLASMA-DERIVED PRODUCTS, BY REGION 49
TABLE 2 PER CAPITA CONSUMPTION OF IVIG AND ALBUMIN, BY REGION/COUNTRY 51
TABLE 3 MAJOR LOCAL PLAYERS IN CHINA 52
TABLE 4 FRACTIONATION CAPACITY EXPANSION BY MAJOR PLAYERS 55
TABLE 5 GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 59
TABLE 6 GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 59
TABLE 7 GLOBAL ALBUMIN MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 60
TABLE 8 GLOBAL IMMUNOGLOBULIN MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 61
TABLE 9 GLOBAL IMMUNOGLOBULIN MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 62
TABLE 10 GLOBAL IVIG MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 63
TABLE 11 GLOBAL SCIG MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 64
TABLE 12 GLOBAL OTHER IMMUNOGLOBULINS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 65
TABLE 13 GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 67
TABLE 14 GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE,
BY REGION, 2012-2019 ($MILLION) 67
TABLE 15 GLOBAL FACTOR VIII MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 68
TABLE 16 GLOBAL FACTOR IX MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 69
TABLE 17 GLOBAL FACTOR XIII MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 70
TABLE 18 GLOBAL PCC MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 71
TABLE 19 GLOBAL VWF MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 72
TABLE 20 FIBRINOGEN CONCENTRATES MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 73
TABLE 21 GLOBAL PROTEASE INHIBITORS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 74
TABLE 22 GLOBAL OTHER PLASMA PRODUCTS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 75
TABLE 23 PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION) 79
TABLE 24 PLASMA FRACTIONATION MARKET SIZE FOR NEUROLOGY, BY COUNTRY,
2012-2019 ($MILLION) 80
TABLE 25 PLASMA FRACTIONATION MARKET SIZE FOR HEMATOLOGY, BY COUNTRY,
2012-2019 ($MILLION) 82
TABLE 26 PLASMA FRACTIONATION MARKET SIZE FOR IMMUNOLOGY, BY COUNTRY,
2012-2019 ($MILLION) 83
TABLE 27 PLASMA FRACTIONATION MARKET SIZE FOR CRITICAL CARE, BY COUNTRY,
2012-2019 ($MILLION) 84
TABLE 28 PLASMA FRACTIONATION MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2012-2019 ($MILLION) 85
TABLE 29 PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 88
TABLE 30 GLOBAL PLASMA FRACTIONATION MARKET SIZE FOR HOSPITALS AND CLINICS,
BY REGION, 2012-2019 ($MILLION) 89
TABLE 31 GLOBAL PLASMA FRACTIONATION MARKET SIZE FOR CLINICAL RESEARCH LABORATORIES, BY REGION, 2012-2019 ($MILLION) 90
TABLE 32 GLOBAL PLASMA FRACTIONATION MARKET SIZE FOR ACADEMIC INSTITUTES,
BY REGION, 2012-2019 ($MILLION) 91
TABLE 33 NORTH AMERICA: PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 98
TABLE 34 NORTH AMERICA: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 98
TABLE 35 NORTH AMERICA: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 98
TABLE 36 NORTH AMERICA: COAGULATION FACTOR CONCENTRATES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 99
TABLE 37 NORTH AMERICA: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 99
TABLE 38 NORTH AMERICA: PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 100
TABLE 39 U.S.: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 101
TABLE 40 U.S.: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 102
TABLE 41 U.S.: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 102
TABLE 42 U.S.: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 103
TABLE 43 U.S.: PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 103
TABLE 44 CANADA: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 104
TABLE 45 CANADA: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 105
TABLE 46 CANADA: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 105
TABLE 47 CANADA: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 106
TABLE 48 CANADA: PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 106
TABLE 49 EUROPE: PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 108
TABLE 50 EUROPE: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 109
TABLE 51 EUROPE: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 109
TABLE 52 EUROPE: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 110
TABLE 53 EUROPE: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 110
TABLE 54 EUROPE: PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 111
TABLE 55 GERMANY: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 112
TABLE 56 GERMANY: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 112
TABLE 57 GERMANY: COAGULATION FACTOR CONCENTRATES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 113
TABLE 58 GERMANY: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 113
TABLE 59 GERMANY: PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 114
TABLE 60 ITALY: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 115
TABLE 61 ITALY: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 115
TABLE 62 ITALY: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 116
TABLE 63 ITALY: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 116
TABLE 64 ITALY: PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 117
TABLE 65 SPAIN: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 118
TABLE 66 SPAIN: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 118
TABLE 67 SPAIN: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 119
TABLE 68 SPAIN: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 119
TABLE 69 SPAIN: PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 120
TABLE 70 FRANCE: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 121
TABLE 71 FRANCE: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 121
TABLE 72 FRANCE: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 122
TABLE 73 FRANCE: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 122
TABLE 74 FRANCE: PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 123
TABLE 75 U.K.: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 124
TABLE 76 U.K.: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 124
TABLE 77 U.K.: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 125
TABLE 78 U.K.: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 125
TABLE 79 U.K.: PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 126
TABLE 80 ROE: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 127
TABLE 81 ROE: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 127
TABLE 82 ROE: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 128
TABLE 83 ROE: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 128
TABLE 84 ROE: PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 129
TABLE 85 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 131
TABLE 86 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 131
TABLE 87 ASIA-PACIFIC: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 132
TABLE 88 ASIA-PACIFIC: COAGULATION FACTOR CONCENTRATES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 132
TABLE 89 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 133
TABLE 90 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 133
TABLE 91 JAPAN: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 134
TABLE 92 JAPAN: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 135
TABLE 93 JAPAN: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 135
TABLE 94 JAPAN: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 136
TABLE 95 JAPAN: PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 136
TABLE 96 CHINA: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 137
TABLE 97 CHINA: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 138
TABLE 98 CHINA: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 138
TABLE 99 CHINA: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 139
TABLE 100 CHINA: PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 139
TABLE 101 INDIA: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 140
TABLE 102 INDIA: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 141
TABLE 103 INDIA: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 141
TABLE 104 INDIA: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 142
TABLE 105 INDIA: PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 142
TABLE 106 REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 143
TABLE 107 REST OF ASIA-PACIFIC: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 144
TABLE 108 REST OF ASIA-PACIFIC: COAGULATION FACTOR CONCENTRATES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 144
TABLE 109 REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION) 145
TABLE 110 REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 145
TABLE 111 ROW: PLASMA FRACTIONATION MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 146
TABLE 112 ROW: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 146
TABLE 113 ROW: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 147
TABLE 114 ROW: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 147
TABLE 115 ROW: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 148
TABLE 116 ROW: PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 148
TABLE 117 LATIN AMERICA: PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 149
TABLE 118 LATIN AMERICA: IMMUNOGLOBULIN MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 150
TABLE 119 LATIN AMERICA: COAGULATION FACTOR CONCENTRATES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 150
TABLE 120 LATIN AMERICA: PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 151
TABLE 121 LATIN AMERICA: PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 151
TABLE 122 MIDDLE EAST AND AFRICA: PLASMA FRACTIONATION MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 152
TABLE 123 MIDDLE EAST AND AFRICA: IMMUNOGLOBULIN MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 153
TABLE 124 MIDDLE EAST AND AFRICA: COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 153
TABLE 125 MIDDLE EAST AND AFRICA: PLASMA FRACTIONATION MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 154
TABLE 126 MIDDLE EAST AND AFRICA: PLASMA FRACTIONATION MARKET SIZE,
BY END USER, 2012-2019 ($MILLION) 154
TABLE 127 GROWTH STRATEGY MATRIX, 2011-2014 156
TABLE 128 EXPANSIONS, 2011-2014 159
TABLE 129 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND ALLIANCES, 2011-2014 160
TABLE 130 NEW PRODUCT LAUNCHES, 2011-2014 161
TABLE 131 MERGERS AND ACQUISITIONS, 2011-2014 162
TABLE 132 PRODUCT ACQUISITION, 2011-2014 162


LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY 20
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 21
FIGURE 3 BOTTOM-UP APPROACH 22
FIGURE 4 TOP-DOWN APPROACH 22
FIGURE 5 DATA TRIANGULATION METHODOLOGY 23
FIGURE 6 IVIG WILL CONTINUE TO DOMINATE THE GLOBAL PLASMA FRACTIONATION MARKET DURING THE FORECAST PERIOD 27
FIGURE 7 GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION,
2014 VS. 2019 ($MILLION) 28
FIGURE 8 GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END USER,
2014 VS. 2019 ($MILLION) 29
FIGURE 9 NORTH AMERICA DOMINATED THE GLOBAL PLASMA FRACTIONATION MARKET IN 2013 30
FIGURE 10 EXPANSIONS ACCOUNTED FOR THE MAJOR STRATEGY ADOPTED BY MARKET PLAYERS DURING THE FORECAST PERIOD 31
FIGURE 11 ATTRACTIVE GROWTH OPPORTUNITIES IN THE GLOBAL PLASMA FRACTIONATION MARKET 32
FIGURE 12 ALBUMIN ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA-PACIFIC PLASMA FRACTIONATION MARKET IN 2013 33
FIGURE 13 THE U.S. COMMANDED ABOUT ONE-THIRD SHARE OF THE GLOBAL PLASMA FRACTIONATION MARKET 34
FIGURE 14 CHINA TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD 35
FIGURE 15 NORTH AMERICA DOMINATES THE PLASMA FRACTIONATION MARKET IN ALL THE END-USER SEGMENTS IN 2014 36
FIGURE 16 GROWING USE OF IMMUNOGLOBULIN AND RISING AGING POPULATION TO SPUR THE DEMAND FOR PLASMA PRODUCTS 39
FIGURE 17 DEMOGRAPHIC GROWTH TRENDS OF THE ELDERLY POPULATION 41
FIGURE 18 INCREASING CONSOLIDATION AND RISING ADOPTION OF SCIG ARE THE LEADING INDUSTRY TRENDS 46
FIGURE 19 PLASMA FRACTIONATION MARKET IN CHINA VS. DEVELOPED COUNTRIES,
2014 VS. 2019 50
FIGURE 20 DOMESTIC PLAYERS DOMINATED THE CHINA ALBUMIN MARKET IN 2013 51
FIGURE 21 PORTER'S FIVE FORCES ANALYSIS 52
FIGURE 22 STRATEGIC BENCHMARKING: MAJOR PLAYERS LARGELY ADOPTED ORGANIC GROWTH STRATEGIES 56
FIGURE 23 IMMUNOGLOBULIN WILL CONTINUE TO DOMINATE THE GLOBAL PLASMA FRACTIONATION MARKET IN THE FORECAST PERIOD 58
FIGURE 24 FACTOR VIII WILL CONTINUE TO DOMINATE THE COAGULATION FACTOR CONCENTRATES MARKET IN THE FORECAST PERIOD 66
FIGURE 25 NEUROLOGY SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL PLASMA FRACTIONATION MARKET IN THE FORECAST PERIOD 78
FIGURE 26 HOSPITALS AND CLINICS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL PLASMA FRACTIONATION MARKET IN THE FORECAST PERIOD 87
FIGURE 27 GEOGRAPHIC SNAPSHOT (2014-2019) - RAPID GROWTH MARKETS ARE EMERGING AS NEW HOT SPOTS 95
FIGURE 28 CHINA OFFERS HIGH GROWTH POTENTIAL FOR ALL PRODUCT CATEGORIES 95
FIGURE 29 NORTH AMERICAN PLASMA FRACTIONATION MARKET SNAPSHOT: INCREASING USE OF LABEL AND OFF LABEL USE OF IMMUNOGLOBULIN TO DRIVE MARKET GROWTH 97
FIGURE 30 GERMANY IS THE MAJOR MARKET FOR PLASMA FRACTIONATION IN EUROPE 108
FIGURE 31 APAC PLASMA FRACTIONATION MARKET SNAPSHOT - CHINA IS THE MOST LUCRATIVE MARKET 130
FIGURE 32 COMPANIES ADOPTED EXPANSION AND AGREEMENTS AS KEY GROWTH STRATEGIES 155
FIGURE 33 GLOBAL PLASMA FRACTIONATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2013 157
FIGURE 34 BATTLE FOR MARKET SHARE: EXPANSION WAS THE KEY STRATEGY 159

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Market Study on Disposable Blood Bags: Increasing Tender Based Procurement of Blood Collection Bags by Not-For-Profit Organizations and Public Healthcare Facilities to Drive Market by 2024

Global Market Study on Disposable Blood Bags: Increasing Tender Based Procurement of Blood Collection Bags by Not-For-Profit Organizations and Public Healthcare Facilities to Drive Market by 2024

  • $ 4900
  • Industry report
  • September 2016
  • by Persistence Market Research

This Persistence Market Research (PMR) report examines the ‘Global Disposable Plastic Blood Bags Market’ for the period 2016–2024. The primary objective of the report is to offer updates and information ...

2016-2021  Emerging US Diagnostics Market: Instrument and Reagent Supplier Shares by Test, Business Environment, Market Structure

2016-2021 Emerging US Diagnostics Market: Instrument and Reagent Supplier Shares by Test, Business Environment, Market Structure

  • $ 4350
  • Industry report
  • November 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume ...

2016-2021  Emerging US Diagnostic Testing Market: Segment Forecasts and Supplier Shares by Test

2016-2021 Emerging US Diagnostic Testing Market: Segment Forecasts and Supplier Shares by Test

  • $ 4350
  • Industry report
  • November 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.